Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2008
12/04/2008US20080300243 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
12/04/2008US20080300237 Pharmaceutically Active Diazepanes
12/04/2008US20080300236 Quinoline-derived amide modulators of vanilloid vr1 receptor
12/04/2008US20080300234 N-(1-Methyl-1-phenyl-ethyl)-3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-benzenesulfonamide, useful in the treatment of breast cancer
12/04/2008US20080300232 N-Piperidine Derivatives as Ccr3 Modulators
12/04/2008US20080300216 Dutpase Inhibitors
12/04/2008CA2688375A1 Spirocyclopropyl piperidine derivatives
12/04/2008CA2688326A1 Tetrahydroisoquinolin-1-one derivative or salt thereof
12/04/2008CA2687973A1 ((bicylicheteroaryl) imidazolyl)methylheteroaryl compounds as adrenergic receptor agonists
12/04/2008CA2687948A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity
12/04/2008CA2687821A1 Benzimidazolone chymase inhibitors
12/04/2008CA2687132A1 4' substituted compounds having 5-ht6 receptor affinity
12/04/2008CA2685797A1 Improved synthesis of (2s-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3-dioxolane-4-methanol methanesulfonate(ester)
12/03/2008EP1997856A1 Optical recording medium and azo metal chelate compound
12/03/2008EP1997811A2 Indazole, benzoxazole and pyrazolopyridine derivatives as P38 kinase inhibitors
12/03/2008EP1997810A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1997809A2 Indazole, benzoxazole and pyrazolopyridine derivatives for medical use
12/03/2008EP1996585A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/03/2008EP1996580A2 Pyrrazole derivatives as sigma receptors antagonists
12/03/2008EP1996579A2 Antibiotic compounds
12/03/2008EP1996555A1 Compounds which potentiate ampa receptor and uses thereof in medicine
12/03/2008EP1996546A2 Substituted gamma lactams as prostaglandin ep2 agonists
12/03/2008EP1996545A1 Soluble epoxide hydrolase inhibitors and methods of using same
12/03/2008EP1996202A1 Chemical compounds
12/03/2008EP1737463B1 Pyrimidines with tie2 (tek) activity
12/03/2008EP1492785B1 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
12/03/2008EP1480954B1 Vanilloid receptor modulators
12/03/2008EP1458700B1 Substituted 2-phenyl benzofurans as estrogenic agents
12/03/2008EP1250337B1 Substituted homopiperidinyl benzimidazole analogues as fundic relaxants
12/03/2008CN101316846A Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, IBS and functional dyspepsia
12/03/2008CN101316840A 1,5-substituted indol-2-yl amide derivatives
12/03/2008CN101316837A Substituted pyrrolones as allosteric modulators of glucokinase
12/03/2008CN101314592A Morpholine ornidazole metabolite in vivo and midbody, and preparation thereof
12/03/2008CN100439374C Epothilone derivatives
12/03/2008CN100439357C Benzo [b][1,4] dioxepine derivatives
12/03/2008CN100439351C Benzofuran derivative
12/03/2008CN100439340C 3-cyanoquinolines, 3-cyano-1,6-naphthyridines, and 3-cyano-1,7-naphthyridines as protein kinase inhibitors
12/03/2008CN100439337C Phenyl substituted piperidine compounds for use as PPAR activators
12/02/2008US7459558 Enzyme inhibitor on NO-synthase enzymes; treating STROKE, NEURODEGENERATIVE DISEASES, preventing ISCHEMIC OR HEMORRAGIC CARDIAC OR CEREBRAL INFARCTIONS; inhibiting lipidic peroxidation
12/02/2008US7459556 Process for preparing substituted 8-azabicyclo[3.2.1]octan-3-ols
12/02/2008US7459555 2H-naphtho(1,2-b) pyrans photochromatic dyes useful in synthetic resin material (ophthalmic lens)
12/02/2008US7459480 Benzodioxepine derivatives
12/02/2008US7459473 1-(phenylmethyl)sulfonyl-2-hydroxymethyl pyrrolidine for example; use treating neurological disorders including physically damaged nerves and neurodegenerative diseases; treating alopecia and promoting hair growth
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459465 Isoquinoline compound and pharmaceutical use thereof
12/02/2008US7459462 Water soluble groups on ring A; antitumor antibiotics; 1-Desoxy-5-C-[(8R)-4',9,9'-trihydroxy-6'-methoxy-1,1',3',5',8'-pentaoxo-1,1',2,3',5',6,7,8'-octahydrospiro[cyclopenta[g]isoquinoline-8,2'-cyclopenta[b]-naphthalene]-3-yl]pentitol; topoisomerase inhibitors; cyclodextrin inclusions; stereoisomers
12/02/2008US7459460 Trisubstituted heteroaromatic compounds as calcium sensing receptor modulators
12/02/2008US7459456 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent
12/02/2008US7459454 Aminopyrazine derivatives and compositions
12/02/2008US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
12/02/2008US7459452 Dihydroxypyrimidine carboxamide inhibitors of HIV integrase
12/02/2008US7459442 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
12/02/2008CA2461622C Substituted benzimidazole compounds and their use for the treatment of cancer
12/02/2008CA2460005C Enhancement of learning and memory and treatment of amnesia with the use of fused pyrazoles
12/02/2008CA2424600C Aliphatic nitrogenous five-membered ring compounds
12/02/2008CA2344144C Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
12/02/2008CA2265672C Pyrazinones and triazinones and their derivatives thereof
12/02/2008CA2248300C Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament, and pharmaceutical preparations comprising them
12/02/2008CA2186380C Novel carbamates and ureas as modifiers of multi-drug resistance
12/02/2008CA2172663C Improved reagents for a cannabinoid immunoassay
11/2008
11/27/2008WO2008144602A1 Deuterated zamifenacin derivatives
11/27/2008WO2008143759A1 Pyrimidinones as casein kinase ii (ck2) modulators
11/27/2008WO2008143263A1 1-substituted tetrahydroisoquinoline compound
11/27/2008WO2008142986A1 NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE HAVING 11 β-HYDROXYSTEROID DEHYDROGENASE TYPE I INHIBITORY ACTIVITY
11/27/2008WO2008142454A1 Bicyclic aryl and heteroaryl compounds for the treatment of metabolic disorders
11/27/2008WO2008142140A2 Novel 2,3-diamino-quinazolinone derivatives and their medical use
11/27/2008WO2008141462A1 Novel case of renin inhibitors
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2008046072A3 Chemical inducers of neurogenesis
11/27/2008WO2007133706A3 Antibiotic-bound poly (caprolactone) polymer
11/27/2008WO2006087143A8 Novel processes for the preparation of a 2h-chromene
11/27/2008WO2005025498A3 Substituted acetanilides and benzamides for the treatment of asthma and pulmonary inflammation
11/27/2008US20080293943 Process for the Preparation of 5-(4-[4-(5-Cyano-3-Indolyl)Butyl]-1-Piperazinyl)Benzofuran-2-Carboxamide
11/27/2008US20080293939 Quinazolinone derivatives useful as anti-hyperalgesic agents
11/27/2008US20080293800 Cytotoxic Compounds and Conjugates
11/27/2008US20080293778 Arylvinylazacycloalkane Compounds and Methods of Preparation and Use Thereof
11/27/2008US20080293770 Psychological disorders; cognition activators
11/27/2008US20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity
11/27/2008US20080293747 Chemical Synthesis of a Highly Potent Epothilone
11/27/2008US20080293745 New amino-alkyl-amide derivatives as CCR3 receptor ligands
11/27/2008US20080293730 Tricyclo Substituted Amides
11/27/2008US20080293727 Amine hydroxyalkyl sulfonamides as enzyme inhibitors; for example, N-1-(3-((3-acetylamino-4-fluoro-benzenesulfonyl)-benzyl-amino)-(1S,2 syn)-1-benzyl-2-hydroxy-propyl)-2-((quinoline-2-carbonyl)-amino)-succinamide; may be used as anti-viral agents against the HIV-1 and HIV-2 viruses
11/27/2008US20080293696 2-Aminoarylcarboxamides Useful as Cancer Chemotherapeutic Agents
11/27/2008US20080293692 Amidating a succinamic acid with a 3-aminolactam to prepare compounds, such as N1-[1,3-dihydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,4-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(allyl)-butanediamide
11/27/2008US20080293668 [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/27/2008US20080293573 Use as pesticide, microbiocide, or herbicide
11/27/2008US20080292587 Oximyl dipeptide hepatitis c protease inhibitors
11/27/2008US20080292582 imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
11/27/2008CA2688057A1 Novel case of renin inhibitors
11/27/2008CA2687958A1 1-substituted tetrahydroisoquinoline compound
11/27/2008CA2687283A1 Quinazolin-oxime derivatives as hsp90 inhibitors
11/27/2008CA2686016A1 Quinoline derivatives as pi3 kinase inhibitors
11/26/2008EP1995242A1 Novel 1,2,3,4-tetrahydroquinoxaline derivative having glucocorticoid receptor binding activity
11/26/2008EP1995240A1 Quinolone derivative or pharmaceutically acceptable salt thereof
11/26/2008EP1994015A1 Dibenzyl amine derivatives as cetp inhibitors
11/26/2008EP1994011A1 Sulfonyl benzimidazole derivatives
11/26/2008EP1994004A2 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive allosteric modulators of mglur2-receptors
11/26/2008EP1756084B1 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
11/26/2008EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity